Literature DB >> 10196253

Enrichment of a precore-minus mutant of duck hepatitis B virus in experimental mixed infections.

Y Y Zhang1, J Summers.   

Abstract

A precore-deficient mutant of duck hepatitis B virus (DHBV) produced by site-directed mutagenesis was tested for its ability to compete with wild-type virus in a mixed infection of 3-day-old ducklings. The mutation was shown to produce a cis-acting defect, resulting in a replication rate that was about one-half that of wild-type virus. Accordingly, wild-type virus was rapidly selected during the spread of infection. During the chronic phase of the infection, however, two selection patterns were seen. In 4 of 10 ducks, the wild-type virus slowly replaced the precore mutant. In another four ducks, the precore mutant virus slowly replaced the wild-type virus. In the remaining two ducklings, ratios of wild-type and precore mutant virus fluctuated, with wild-type virus slowly predominating. The replacement of wild-type virus was not due to the emergence of a rapidly replicating variant of the precore mutant, since genomes cloned from the infected ducks retained their original replication defect. Replacement of wild-type virus, however, correlated with elevated anti-core antibody titers, which continued to increase with time. The selection of a precore-negative strain of DHBV may be analogous to the selection for precore mutants of HBV during chronic hepatitis in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196253      PMCID: PMC104136     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Natural populations of woodchuck hepatitis virus contain variant precore and core sequences including a premature stop codon in the epsilon motif.

Authors:  D H Li; J E Newbold; J M Cullen
Journal:  Virology       Date:  1996-06-01       Impact factor: 3.616

2.  Infection initiated by the RNA pregenome of a DNA virus.

Authors:  M J Huang; J Summers
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus.

Authors:  R J Lenhoff; J Summers
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

4.  Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes.

Authors:  R J Lenhoff; J Summers
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

5.  A new hepadnavirus endemic in arctic ground squirrels in Alaska.

Authors:  P Testut; C A Renard; O Terradillos; L Vitvitski-Trepo; F Tekaia; C Degott; J Blake; B Boyer; M A Buendia
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  Woodchuck hepatitis virus X protein is required for viral infection in vivo.

Authors:  F Zoulim; J Saputelli; C Seeger
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 7.  Diagnostic markers of viral hepatitis B and C.

Authors:  C Trépo; F Zoulim; C Alonso; M A Petit; C Pichoud; L Vitvitski
Journal:  Gut       Date:  1993       Impact factor: 23.059

Review 8.  The emergence of envelope and precore/core variants of hepatitis B virus: the potential role of antibody selection.

Authors:  H C Thomas
Journal:  J Hepatol       Date:  1995       Impact factor: 25.083

9.  A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients.

Authors:  S Günther; B C Li; S Miska; D H Krüger; H Meisel; H Will
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus.

Authors:  R J Lenhoff; C A Luscombe; J Summers
Journal:  Hepatology       Date:  1999-02       Impact factor: 17.425

View more
  16 in total

1.  Low dynamic state of viral competition in a chronic avian hepadnavirus infection.

Authors:  Y Y Zhang; J Summers
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  Point mutations upstream of hepatitis B virus core gene affect DNA replication at the step of core protein expression.

Authors:  Michael Guarnieri; Kyun-Hwan Kim; Genie Bang; Jisu Li; Yonghong Zhou; Xiaoli Tang; Jack Wands; Shuping Tong
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 4.  Avian hepatitis B viruses: molecular and cellular biology, phylogenesis, and host tropism.

Authors:  Anneke Funk; Mouna Mhamdi; Hans Will; Hüseyin Sirma
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

5.  A high level of mutation tolerance in the multifunctional sequence encoding the RNA encapsidation signal of an avian hepatitis B virus and slow evolution rate revealed by in vivo infection.

Authors:  Bernadette Schmid; Christine Rösler; Michael Nassal
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 6.  Molecular biology of hepatitis B virus infection.

Authors:  Christoph Seeger; William S Mason
Journal:  Virology       Date:  2015-03-07       Impact factor: 3.616

7.  Immune selection during chronic hepadnavirus infection.

Authors:  William S Mason; Sam Litwin; Allison R Jilbert
Journal:  Hepatol Int       Date:  2007-12-14       Impact factor: 6.047

8.  Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen.

Authors:  Kathie-Anne Walters; Michael A Joyce; William R Addison; Karl P Fischer; D Lorne J Tyrrell
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Antiviral resistance and hepatitis B therapy.

Authors:  Marc G Ghany; Edward C Doo
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

Review 10.  New perspective on the natural course of chronic HBV infection.

Authors:  Yong-Yuan Zhang; Ke-Qin Hu; Zhongping Duan
Journal:  Front Med       Date:  2014-05-29       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.